Skip to content
MedsAcross

Medicine

Piperacillin and Tazobactam 36 g/4.5 g per 152 mL powder for injection

Available on requestPrescription onlyUS FDA Cold chainGeneric name

Piperacillin and Tazobactam 36 g/4.5 g per 152 mL powder for injection is a generic prescription medicine for intravenous use, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Cold chain

Discard unused portion after 24 hours if stored at room temperature 20° to…

Key facts

Active ingredient (INN)
Piperacillin and Tazobactam
Brand
Sold under the generic name
Strength
36 g/4.5 g per 152 mL
Dosage form
Powder for injection
Route
Intravenous
Packs
1 bottle
Manufacturer
Sagent Pharmaceuticals
Origin register
US FDA, United States
Storage
Discard unused portion after 24 hours if stored at room temperature 20° to 25°C (68° to 77°F), or after 48 hours if stored at refrigerated temperature 2° to 8°C (36° to 46°F). Store at 20° to 25°C (68° to 77°F), excursions permitted between 15° and 30°C (59° and 86°F). After Reconstitution: DO NOT FREEZE RECONSTITUTED SOLUTION.
Cold chain
Yes, shipped temperature controlled
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
HS code (indicative)
3004.10Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
28 February 2021
Identifiers
RxCUI 312447DailyMed set ID 83f4adcd-893c-4e9e-8f2b-e06299dcf34dNDC 25021-181Application ANDA208675

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

PackCodeLabelerMarketed since
1 bottle in 1 carton / 152 mL in 1 bottle25021-181-99Sagent Pharmaceuticals28 February 2021

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 22 October 1993Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Other strengths and forms of Piperacillin and Tazobactam

Clinical summary

Piperacillin and Tazobactam is a fixed-dose combination of a penicillin-class antibacterial and a beta lactamase inhibitor indicated for the treatment of intra-abdominal infections in adult and pediatric patients 2 months of age and older. MedsAcross supplies Piperacillin and Tazobactam for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Piperacillin and Tazobactam

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Piperacillin and Tazobactam 36 g/4.5 g per 152 mL powder for injection for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.